Monkeypox Today

Authored by
Staff
Last reviewed
December 1, 2022

Monkeypox Today

Monkeypox Today is a worldwide publisher of information people can trust to make informed decisions regarding monkeypox virus (MPXV) prevention, treatment, and vaccine selection. In addition, Monkeypox Today's research-based information is translated into a main-street language people can easily understand.

As of December 2022, the U.S. CDC reported over one hundred countries had reported about 81,000 monkeypox patients and 61 related fatalities. And on November 28, 2022,  the U.S. HHS confirmed its support for the World Health Organization (WHO) renaming monkeypox disease to Mpox. In addition, the WHO published Monkeypox Outbreak Global Trends on November 28, 2022.

On October 27, 2022, the Mpox public health emergency in San Francisco ended, followed by New York in November 2022.

Mpox Information

Vaccines: Mpox vaccines authorized and in development

Treatments: Pre-exposure prophylaxis and Post-exposure prophylaxis Mpox treatments.

Testing: Diagnostic laboratories offer a variety of tests to identify the infectious status and Mpox virus types.

Research: Unbiased, peer-reviewed clinical research that offers insights into science.

Disease: The Mpox virus is part of the same family of viruses as the variola virus that causes smallpox.

Information Sources

Monkeypox Today's information sources include the WHO, the U.S. CDC, U.S. FDA, European Medicines Agency, and the U.K. Health Services Agency, research publications, academic institutions, and industry participants. Information from these world-class enterprises is aggregated and curated for mobile readership.